Cargando…
How we use hepatic arterial infusion chemotherapy in the new era of systemic therapy?
Autores principales: | Ogasawara, Sadahisa, Kanogawa, Naoya, Kato, Naoya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577980/ https://www.ncbi.nlm.nih.gov/pubmed/36268255 http://dx.doi.org/10.21037/hbsn-22-396 |
Ejemplares similares
-
Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia Assessment
por: Yamasaki, Takahiro, et al.
Publicado: (2022) -
Incidental tumor necrosis caused by the interventional alteration of hepatic arterial flow in patients with advanced hepatocellular carcinoma
por: Suzuki, Eiichiro, et al.
Publicado: (2014) -
Effect of Previous Interferon-based Therapy on Recurrence after Curative Treatment of Hepatitis C Virus-related Hepatocellular Carcinoma
por: Saito, Tomoko, et al.
Publicado: (2014) -
Switching to systemic therapy after locoregional treatment failure: Definition and best timing
por: Ogasawara, Sadahisa, et al.
Publicado: (2020) -
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity
por: Iwamoto, Hideki, et al.
Publicado: (2023)